Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Clinical trial NCT01848054 · COMPLETED

Trial details

NCT number: NCT01848054
Sponsor: Orexo AB
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid-Related Disorders Opiate Dependence

Start date: 2013-06-01
Primary completion: 2014-01-01
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.